Roybal Centers for Translational Research on Dementia Care Provider Support (P30 Clinical Trial Required)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) solicits Edward R. Roybal Centers for translational intervention development research for Alzheimer's disease and Alzheimer's disease related dementias (AD-ADRD) care provider support. The purpose of the Roybal Centers is to develop behavioral interventions that improve the health, well-being and/or capacity of individuals and/or systems that provide care to persons with AD-ADRD. Roybal Centers will conduct Stage 0 through IV pilot studies in accordance with the multidirectional, translational NIH Stage Model, to produce potent and implementable principle-driven behavioral interventions. For the purposes of this FOA, Stage I studies and small-scale Stage 0, II, III, and IV studies will be referred to as "pilot" studies.  All applications must include Stage I studies, in which a principle-driven intervention and the intervention's associated materials are created, refined, adapted, and pilot tested for feasibility, acceptability and efficacy.  

Companion FOAs:

RFA-AG-19-006P30 Center Core Grants

RFA-AG-19-008R24 Resource-Related Research Projects


  • Letter of Intent Due Date(s): September 18, 2018
  • Application Due Date(s): October 18, 2018

RFA-AG-19-007 Expiration Date October 19, 2018

Agency Website

Amount Description

NIA expects to fund Centers of different sizes. Application budgets are limited to $500,000 in first-year direct costs (for Management and Administrative Core and Pilot Core).

The maximum project period is 5 years. 

    Funding Type





    Medical - Translational

    External Deadline

    October 18, 2018